Seqera helps Arcus Biosciences Improve Research Productivity and Position Itself for Future Growth
Read the full case studyAim
Provide self-service access to scalable, repeatable pipelines to a broader community of users. Improve efficiency, collaboration, and improve cloud resource utilization.Challenges
- →Previous systems were difficult to use.
- →Pipeline monitoring and traceability.
- →Issues with efficiency and overspending.
- →Need to evolve to a hybrid cloud model.
After deploying Seqera, our researchers rapidly became self-sufficient in launching and monitoring pipelines. This has freed up significant technical resources allowing us to focus on high-value tasks.
Solution
Nextflow
Take advantage of highquality community-curated pipelines and build a more scalable foundation for research and clinical trials.
Seqera
Enable collaborative data analysis at scale by providing an intuitive interface for researchers and clinicians.
AWS Cloud
Results
- →40-50% reduction in cloud spending
- →Ability to segment research from clinical trials
- →Dramatic productivity gains
- →Improved flexibility for future growth
- →Consistent user experience
40-50%
reduction in cloud spending
About
Founded in 2015, Arcus Biosciences is a highly productive, clinical-stage, global biopharmaceutical company with the goal of developing best-in-class molecules and combination therapies for people with cancer. Their team of scientists, physicians, advisors and other leaders is focused on targeting well-understood biological targets and pathways where there is an opportunity to develop new medicines with a potentially improved safety and efficacy profile.
To learn more, visit https://arcusbio.com/
Trusted by Pharma to Deliver Reproducible Results at Enterprise Scale